惠民保从“事后补偿”向“事前预防”转移。 “保险公司与药企之间存在支付悖论,保险公司希望为健康人群投保,只有为健康人群投保越多,才有可能盈利,保险公司的核心诉求是控制赔付成本;药企的客户则是用药人群,药企的核心诉求是追求药品使用,以实现市场价值和研发回报。”近日,在一场研讨会上,复旦大学经济学院副院长许闲教授讲述了药险困境,而这种困境也导致了中国创新药械支付结构中,作为“第三支柱”功能的商业...
Source Link惠民保从“事后补偿”向“事前预防”转移。 “保险公司与药企之间存在支付悖论,保险公司希望为健康人群投保,只有为健康人群投保越多,才有可能盈利,保险公司的核心诉求是控制赔付成本;药企的客户则是用药人群,药企的核心诉求是追求药品使用,以实现市场价值和研发回报。”近日,在一场研讨会上,复旦大学经济学院副院长许闲教授讲述了药险困境,而这种困境也导致了中国创新药械支付结构中,作为“第三支柱”功能的商业...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.